Crispr Therapeutics AG (CRSP) — Financial Flexibility Index
Crispr Therapeutics AG (CRSP) has a Financial Flexibility Index of -0.12x as of March 2026. Free cash flow of $-108.39 Million (operating CF $-108.90 Million minus capex $504.00K) represents 0% of total liabilities ($911.26 Million). Check how aggressively does Crispr Therapeutics AG reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Crispr Therapeutics AG Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Crispr Therapeutics AG across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Crispr Therapeutics AG.
Annual Financial Flexibility Index for Crispr Therapeutics AG (2014–2025)
Year-by-year free cash flow to debt coverage for Crispr Therapeutics AG. Explore CRSP cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.00x | $-344.10 Million | $-345.01 Million | $343.43 Million | ▼ -120.5% |
| 2024 | -0.45x | $-140.87 Million | $-142.77 Million | $309.95 Million | ▲ +37.2% |
| 2023 | -0.72x | $-250.91 Million | $-260.38 Million | $346.77 Million | ▲ +42.0% |
| 2022 | -1.25x | $-458.55 Million | $-495.74 Million | $367.58 Million | ▼ -170.8% |
| 2021 | 1.76x | $620.68 Million | $538.97 Million | $352.42 Million | ▲ +231.1% |
| 2020 | -1.34x | $-220.01 Million | $-238.37 Million | $163.73 Million | ▼ -370.0% |
| 2019 | 0.50x | $63.36 Million | $56.68 Million | $127.33 Million | ▲ +151.5% |
| 2018 | -0.97x | $-93.47 Million | $-96.24 Million | $96.82 Million | ▼ -29.4% |
| 2017 | -0.75x | $-62.28 Million | $-70.10 Million | $83.51 Million | ▼ -59.9% |
| 2016 | -0.47x | $-52.29 Million | $-55.31 Million | $112.12 Million | ▼ -245.2% |
| 2015 | 0.32x | $60.58 Million | $59.43 Million | $188.55 Million | ▲ +175.1% |
| 2014 | -0.43x | $-3.64 Million | $-4.79 Million | $8.50 Million | — |